ADTCA 2024 is enabled by Platinum Partners:

BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers.

IFPMA is the voice of the innovative pharmaceutical industry, collaborating for global health progress to improve lives everywhere. IFPMA champions innovation as the driving force behind progress in healthcare, contributing to healthier lives and societies.

The Antimicrobial Resistance Fighter Coalition aspires to change behaviors across the globe that will maintain the effectiveness of antibiotics for future generations by increasing awareness of antimicrobial resistance via education, training, and partnerships.

LifeArc progresses promising early-stage science for some of the most under-served health conditions by funding it, forming partnerships, and providing scientific and commercialisation support.

Bangalore Bioinnovation Centre is a joint initiative of Department of Biotechnology, Government of India and Department of Electronics, IT, BT and S&T, Government of Karnataka. It works closely with Karnataka Innovation & Technology Society (KITS), a nodal centre for implementing schemes of the Department of Electronics, IT, BT and S&T, Government of Karnataka & its startup cell. It is a State-of-the-art translational research and entrepreneurship centre catering to all the needs of start-ups in life science.

ADTCA 2024 is enabled by GOLD Partners:

Molzym is committed to the development of innovative solutions to serve biological research and diagnosis of infectious diseases. Its developmental efforts are focused on new processes enabling and facilitating the molecular diagnosis of infectious diseases caused by bacteria and fungi an environment where the brightest minds can explore new ideas and find the practical resources to create products and services rooted in innovation.

IHMA is your global antimicrobial partner. IHMA supports all phases of anti-infective therapy development, from discovery through commercialization. We are your essential resource for central, reference, and clinical research laboratory services worldwide.

BSI is protecting the efficacy of antibiotics for future generations with the BSI Kitemark™ for minimized risk of antimicrobial resistance certification programme.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed